Citigroup
STTK icon

Citigroup’s Shattuck Labs STTK Stock Holding History

Citigroup’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Sell
28,771
-46,234
-62% -$288K ﹤0.01% 4341
2026
Q1 		$482K Buy
75,005
+50,173
+202% +$238K ﹤0.01% 3567
2025
Q4 		$90.6K Buy
24,832
+9,724
+64% +$23.2K ﹤0.01% 4362
2025
Q3 		$36.1K Buy
15,108
+6,520
+76% +$7.98K ﹤0.01% 4596
2025
Q2 		$6.8K Sell
8,588
-19,955
-70% -$19.4K ﹤0.01% 5242
2025
Q1 		$27.1K Sell
28,543
-2,532
-8% -$3.12K ﹤0.01% 5029
2024
Q4 		$37.6K Buy
31,075
+2,748
+10% +$3.4K ﹤0.01% 5149
2024
Q3 		$98.9K Buy
28,327
+19,278
+213% +$71.9K ﹤0.01% 4768
2024
Q2 		$34.9K Sell
9,049
-23,083
-72% -$188K ﹤0.01% 4785
2024
Q1 		$287K Sell
32,132
-27,515
-46% -$252K ﹤0.01% 3855
2023
Q4 		$425K Buy
+59,647
New +$163K ﹤0.01% 3522
2023
Q1 		– Sell
-107
Closed -$246 – 5848
2022
Q4 		$246 Sell
107
-513
-83% -$1.28K ﹤0.01% 5578
2022
Q3 		$2K Sell
620
-399
-39% -$1.5K ﹤0.01% 5534
2022
Q2 		$4K Sell
1,019
-1,356
-57% -$4.91K ﹤0.01% 5714
2022
Q1 		$10K Sell
2,375
-5,948
-71% -$33.7K ﹤0.01% 5547
2021
Q4 		$71K Buy
8,323
+5,070
+156% +$69.8K ﹤0.01% 4911
2021
Q3 		$66K Sell
3,253
-41,201
-93% -$882K ﹤0.01% 4596
2021
Q2 		$1.29M Sell
44,454
-1,493
-3% -$43.6K ﹤0.01% 3026
2021
Q1 		$1.34M Buy
45,947
+43,474
+1,758% +$1.83M ﹤0.01% 2760
2020
Q4 		$130K Buy
+2,473
New +$79.5K ﹤0.01% 5324

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $217M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citigroup's STTK Position: Q2 2026 in Review

Citigroup reduced its Shattuck Labs (STTK) stake by 62% in Q2 2026, selling an estimated $288K and leaving 28,771 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #4341.

Citigroup first reported a position in STTK in Q4 2020 and has held it in 20 quarters since. The position peaked at $1.34M in Q1 2021. 100 funds tracked by Wall St. Rank hold STTK as of Q2 2026.

  • Citigroup held 28,771 shares of Shattuck Labs worth $200K as of Q2 2026.
  • Citigroup sold 46,234 Shattuck Labs shares in Q2 2026, an estimated $288K.
  • Shattuck Labs made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4341 holding.
  • Citigroup first reported a position in Shattuck Labs in Q4 2020 and has held it in 20 quarters since.
  • Citigroup's Shattuck Labs position peaked at $1.34M in Q1 2021.
  • 100 funds tracked by Wall St. Rank held Shattuck Labs as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.